Sale!

Cultured AFB Antitubercular DST Rifampicin Test

660 د.إ

-11%

The “Cultured AFB Antitubercular DST Rifampicin Test” is a specialized laboratory analysis aimed at evaluating the susceptibility of Mycobacterium tuberculosis, the bacteria responsible for tuberculosis (TB), to the antibiotic rifampicin. Rifampicin is a critical component of the standard treatment regimen for TB, and resistance to this drug can significantly affect treatment outcomes. The test involves culturing the bacteria from a patient’s clinical sample and then assessing its growth in the presence of rifampicin. This allows for the determination of the bacteria’s sensitivity or resistance to the drug, guiding healthcare providers in tailoring the most effective treatment plan for the patient.

Performed at DNA Labs UAE, a facility known for its advanced diagnostic services, this test is priced at 660 AED. The lab employs state-of-the-art technology and follows stringent protocols to ensure accurate and reliable results, contributing to the effective management of tuberculosis by identifying drug-resistant strains and facilitating appropriate therapeutic interventions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CULTURED AFB ANTITUBERCULAR DST RIFAMPICIN Test

At DNA Labs UAE, we offer the CULTURED AFB ANTITUBERCULAR DST RIFAMPICIN test to determine the susceptibility of Mycobacterium tuberculosis to the antibiotic rifampicin. This test helps guide appropriate treatment for tuberculosis by identifying whether the bacteria are resistant or susceptible to rifampicin.

Test Details

The CULTURED AFB ANTITUBERCULAR DST RIFAMPICIN test is a laboratory test used to determine the susceptibility of Mycobacterium tuberculosis to rifampicin. Rifampicin is one of the first-line drugs used in the treatment of tuberculosis. During the test, a sample of the bacteria is isolated and cultured in the laboratory. The bacteria are then exposed to different concentrations of rifampicin. The growth of the bacteria is monitored, and the minimum inhibitory concentration (MIC) of rifampicin required to prevent bacterial growth is determined. Based on the MIC, the bacteria are classified as either susceptible, intermediate, or resistant to rifampicin.

Susceptible bacteria are effectively killed by the antibiotic, while resistant bacteria are not affected by it. Intermediate bacteria may show some response to the antibiotic, but at concentrations higher than what is typically achievable in the body. The results of the CULTURED AFB ANTITUBERCULAR DST RIFAMPICIN test are crucial in guiding the selection of appropriate antibiotic therapy for the treatment of tuberculosis. If the bacteria are resistant to rifampicin, alternative drugs or drug combinations need to be used to effectively treat the infection.

Test Components and Price

Test Name: CULTURED AFB ANTITUBERCULAR DST RIFAMPICIN Test

Components: Automated Fluorescent

Price: 660.0 AED

Sample Condition

Submit pure growth of Mycobacterium tuberculosis complex on appropriate media in a sterile screw-capped container in a sealed plastic bag. Ship refrigerated OR when used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submitted will be processed for Antitubercular Sensitivity.

Report Delivery

Sample: Daily by 3.30 pm

Report: 21 days

Pre Test Information

No special preparation required.

Test Department

Physician

Conclusion

The CULTURED AFB ANTITUBERCULAR DST RIFAMPICIN test offered by DNA Labs UAE is an essential tool in determining the susceptibility of Mycobacterium tuberculosis to rifampicin. By identifying whether the bacteria are resistant or susceptible to this antibiotic, the test helps guide appropriate treatment for tuberculosis. With a report delivery time of 21 days, our automated fluorescent test provides accurate results to assist physicians in selecting the most effective antibiotic therapy for their patients.

Test Name CULTURED AFB ANTITUBERCULAR DST RIFAMPICIN Test
Components
Price 660.0 AED
Sample Condition Submit pure growth ofMycobacterium tuberculosis complexon appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated ORwhen used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submittedwill be processed for Antitubercular Sensitivity.
Report Delivery Sample Daily by 3.30 pm; Report 21 days
Method Automated Fluorescent
Test type Tuberculosis
Doctor Physician
Test Department:
Pre Test Information No special preparation required
Test Details

The CULTURED AFB ANTITUBERCULAR DST RIFAMPICIN test is a laboratory test used to determine the susceptibility of Mycobacterium tuberculosis (the bacterium that causes tuberculosis) to the antibiotic rifampicin.

Rifampicin is one of the first-line drugs used in the treatment of tuberculosis, and this test helps to guide appropriate treatment by identifying whether the bacteria are resistant or susceptible to rifampicin.

During the test, a sample of the bacteria is isolated and cultured in the laboratory. The bacteria are then exposed to different concentrations of rifampicin. The growth of the bacteria is monitored, and the minimum inhibitory concentration (MIC) of rifampicin required to prevent bacterial growth is determined.

Based on the MIC, the bacteria are classified as either susceptible, intermediate, or resistant to rifampicin. Susceptible bacteria are effectively killed by the antibiotic, while resistant bacteria are not affected by it. Intermediate bacteria may show some response to the antibiotic, but at concentrations higher than what is typically achievable in the body.

The results of the CULTURED AFB ANTITUBERCULAR DST RIFAMPICIN test are crucial in guiding the selection of appropriate antibiotic therapy for the treatment of tuberculosis. If the bacteria are resistant to rifampicin, alternative drugs or drug combinations need to be used to effectively treat the infection.